Skip Navigation
Menu
Original Research |1 May 1980

Sideroblastic Anemia as a Preleukemic Event in Patients Treated for Hodgkin's Disease

MITSUO KITAHARA, M.D.; THOMAS M. COSGRIFF, M.D.; HARMON J. EYRE, M.D.

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
▸Requests for reprints should be addressed to Harmon J. Eyre, M.D.; 50 North Medical Drive; Salt Lake City, UT 84132.
  • Salt Lake City, Utah
×
FULL TEXT

Abstract

Sideroblastic anemia after treatment for Hodgkin's disease was seen in two patients 3 years after completion of radiation therapy and chemotherapy. This was followed in both by the development of myelomonoblastic leukemia. No evidence of recurrent Hodgkin's disease was present in either patient. Our observation suggests that development of sideroblastic anemia in patients previously treated for Hodgkin's disease is probably secondary to the treatment and is a preleukemic event.

FULL TEXT
PDF
Not Available
Citations
Citation

KITAHARA M, COSGRIFF TM, EYRE HJ. Sideroblastic Anemia as a Preleukemic Event in Patients Treated for Hodgkin's Disease. Ann Intern Med. 1980;92:625–627. doi: 10.7326/0003-4819-92-5-625

Download citation file:

© 2018

×
Permissions

Published: Ann Intern Med. 1980;92(5):625-627.

DOI: 10.7326/0003-4819-92-5-625

32 Citations

Related Articles
Annals Consult Guys - The Adult Survivor of Hodgkin Disease: Falling Through the Cracks
Annals of Internal Medicine; 166 (10): CG1
Annals for Educators - 16 May 2017
Annals of Internal Medicine; 166 (10): ED10
Antibody Responses to Polysaccharide and Polysaccharide-Conjugate Vaccines after Treatment of Hodgkin Disease
Annals of Internal Medicine; 123 (11): 828-834
Low-Dose Involved Field Radiation after Chemotherapy in Advanced Hodgkin Disease: A Southwest Oncology Group Randomized Study
Annals of Internal Medicine; 120 (11): 903-912
View MoreView Less

Related Topics
Hematology/Oncology
Leukemia/Lymphoma
Red Cell Disorders

Hematology/Oncology, Leukemia/Lymphoma, Red Cell Disorders.

PubMed Articles
Use of 18F FDG PET and the short temporal response of Hodgkin's disease to RIT.
World J Nucl Med ;17(3):171-177.
18F-FDG PET/CT for response assessment in Hodgkin lymphoma undergoing immunotherapy with checkpoint inhibitors.
Leuk Lymphoma 2018.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2018 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×